IBRX Past Earnings image   This IBRX past earnings page last updated 5/19/2022
IBRX Past Earnings
Data adjusted for IBRX split history

PeriodPast Earnings DateGAAP
Q1 20225/10/2022-0.260
Q4 20213/2/2022-0.230
Q3 202111/12/2021-0.220
Q2 20218/12/2021-0.230
Q1 20215/14/2021-0.210
FY 20203/4/2021-0.890
IBRX Past Revenue
PeriodPast Earnings DateGAAP
Q1 20225/10/20220.01M
Q4 20213/2/20220.00B
Q3 202111/12/20210.07M
Q2 20218/12/20210.00B
Q1 20215/14/20210.00B
FY 20203/4/20210.00B
Quotes delayed 20 minutes

Email EnvelopeFree IBRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
ImmunityBio (IBRX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ICAD Historical Earnings
ICCC Historical Earnings
ICPT Historical Earnings
ICUI Historical Earnings
ICVX Historical Earnings
IDRA Historical Earnings
IDXX Historical Earnings
IDYA Historical Earnings
IGMS Historical Earnings
IIN Historical Earnings

IBRX Past Earnings Q&A

What was the best and worst IBRX past earnings results?
For ImmunityBio, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest IBRX past earnings result in our data set was -0.210/share posted in Q1 2021, while the lowest was in FY 2020 when IBRX posted -0.890/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2021 when IBRX reported 0.00B in revenue, while the quarter with the lowest revenue in our data set was Q1 2022 at 0.01M of revenue.

  Suggested answer: There are 6 IBRX past earnings results in our data set.

On this page we presented the IBRX past earnings date information for ImmunityBio. Reviewing that IBRX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2021, when IBRX posted gaap of -0.210/share. Meanwhile the lowest IBRX past earnings result was in FY 2020, when IBRX posted gaap of -0.890/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2021 when IBRX reported 0.00B in revenue, while the smallest revenue quarter was Q1 2022 when IBRX reported 0.01M in revenue.

Any self directed investor doing their due diligence on IBRX or any other given stock can benefit from researching all of the ImmunityBio past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate ImmunityBio past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for IBRX. Thanks for visiting, and the next time you need to research IBRX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: XXII Average Annual Return, JACK Options Chain, Institutional Holders of ROK.

 

IBRX Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.